Amarin Executives Bulk Up Holdings, Signaling Confidence as New Cardiovascular Drugs Loom
Insider buying fuels confidence in Amarin’s growth—executives pile onto ADS and RSUs, signaling strong belief in new cardiovascular therapeutics and a potential price lift.
3 minutes to read